Join to View Full Profile
950 Campbell AveWest Haven, CT 06516
Phone+1 203-937-3421
Fax+1 203-937-3803
Dr. Tran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2019- Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
Vanderbilt University School of MedicineClass of 2013
Certifications & Licensure
CT State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Biotech Accelerator Award The Blavatnik Fund for Innovation at Yale, 2023
- Stephen A. Sherwin ’70 MD Translational Research Fellowship Award 2023
Clinical Trials
- An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) Start of enrollment: 2019 Jul 18
- XTX202 in Patients With Advanced Solid Tumors Start of enrollment: 2022 Jan 18
- A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) Start of enrollment: 2023 Jul 19
- Join now to see all
Publications & Presentations
PubMed
- MIF as an oncogenic driver of low-heterogeneity melanomas.Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Rajan P Kulkarni, Harriet M Kluger, Richard Bucala
Molecular Oncology. 2025-03-25 - Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.Sarah A Weiss, Dijana Djureinovic, Wei Wei, Thuy Tran, Matthew Austin
Journal of Clinical Oncology. 2025-03-06 - 1 citationsCD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic ...Bianca Pellegrino, Keren David, Stav Rabani, Bar Lampert, Thuy Tran
Plos Biology. 2024-11-01
Press Mentions
Yale Study Highlights Unmet Needs for Patients with Melanoma Who Progress or Relapse After Immunotherapy TreatmentAugust 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
